Days Set Up
Monday - Friday, 8:00am - 4:30pm
Analytic Time

5 days

MiChart Code
Disease Assoc - UVEITIS (HLA-B27)
Soft Order Code
UVEI

Test Updated:

Synonyms

Uveitis - HLA B27
UVEI
Uveitis, HLA
TTYPE
TISSUE TYPING
HLA REPORT
HLA B-27
B27 Antigen
HLA Class I One Locus (Low Resolution)

+ See More

Looking to order a test?

We’ve provided helpful links to make ordering easy.

Find a Requisition

All specimens should be accompanied by a requisition.

Submitting Specimens

Learn about how to properly label and where to ship specimens.

Order Kits and Supplies

MLabs provides all the supplies necessary for the collection of specimens.

Test FAQ

Visit our provider FAQ and learn about common questions to ordering tests.

Test Overview

Test Methodology

Molecular Typing (SSOP)

Test Usage

Uveitis is one of the most common form of inflammatory eye disease and is a significant cause of visual impairment and blindness. Uveitis onset is usually between the ages of 20 to 50 and uncommon in the very young and in the elderly. Patients with a uveitis affected relative who are HLA-B27 positive are at higher risk of developing the disease.

Reference Range

Interpretive report will indicate presence or absence of HLA-B27.

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Specimen Requirements

Normal Volume
10 mL ACD (solution A) or EDTA whole blood; additional specimen may be required for patients with extremely low white cell counts.
Minimum Volume
5 mL ACD (solution A) or EDTA whole blood; additional specimen may be required for patients with extremely low white cell counts.

Billing Information

CPT Code
81373
Pro Fee Code
 
LOINC
 

Have More Questions?

Explore our helpful billing resources:

Our High Standard

Quality that sets us apart

As the reference laboratory division of Michigan Medicine's Department of Pathology, MLabs shares the institution's commitment to applying established quality principles to clinical laboratory testing. Like other large organizations in complex, consequential fields, we rely on an established approach to monitor quality throughout the testing process.

LEARN MORE